TOBYSIGN-D Eye/Ear Drops is a specially formulated combination therapy designed to deliver both antibacterial and anti-inflammatory actions in ophthalmic and otic infections. It combines the efficacy of Tobramycin, a powerful aminoglycoside antibiotic, with Dexamethasone, a synthetic corticosteroid known for its potent anti-inflammatory and immunosuppressive properties. This dual-acting medication is highly effective in treating bacterial infections of the eye (conjunctivitis, blepharitis, keratitis) and ear (otitis externa), especially where inflammation is present alongside infection.

Tobramycin functions by inhibiting protein synthesis in susceptible bacteria, thereby eliminating pathogens responsible for the infection. It is active against a wide range of gram-negative and some gram-positive bacteria, including Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. Its rapid bactericidal action helps in achieving quicker symptom relief and reducing the risk of complications.

Dexamethasone, on the other hand, helps control swelling, redness, and allergic reactions by inhibiting multiple inflammatory cytokines and mediators. Its inclusion in TOBYSIGN-D significantly reduces discomfort, pain, and tissue irritation caused by infections or surgeries, thereby enhancing patient recovery and compliance.

TOBYSIGN-D Eye/Ear Drops are administered topically into the affected eye or ear, depending on the diagnosis. The sterile formulation ensures safety and prevents further microbial contamination. The typical concentration in each mL is Tobramycin 0.3% and Dexamethasone 0.1%, though custom strengths can be manufactured based on client requirements. The drops are usually prescribed 1–2 drops every 4 to 6 hours, with frequency adjusted according to severity and clinical response.

This product is particularly suitable for post-surgical use, such as after cataract surgery or ear tube insertion, to prevent secondary infections and minimize inflammation. It is also effective in managing chronic external otitis and bacterial conjunctivitis, where both infection and inflammation co-exist. Care must be taken not to use it in viral or fungal eye infections, as corticosteroids may worsen those conditions.

Manufactured by BluepillExpress under WHO-GMP and ISO-certified facilities, TOBYSIGN-D meets the highest standards of sterility, precision, and quality. The manufacturing process includes stringent in-process controls, validation procedures, and batch-wise microbial limit testing to ensure safety and efficacy. Packaging is done in tamper-evident LDPE dropper bottles, available in 5 mL and 10 mL fill volumes. Multi-language labeling, private branding, and export-ready packaging are also offered to meet specific regulatory or market needs.

TOBYSIGN-D Eye/Ear Drops are supported with a complete product dossier, including Certificate of Analysis (CoA), Stability Data, Method of Analysis, and if required, CTD (Common Technical Document) format documentation. This makes it ideal for third-party manufacturing as well as for export to both regulated and semi-regulated markets, especially in Africa, Asia, Latin America, and CIS countries.

BluepillExpress offers full support for clients interested in launching ophthalmic or otic products under their own brand. From custom formulation development and F&D support to packaging, export logistics, and documentation, every aspect of manufacturing is handled with professional expertise and strict regulatory compliance.

In summary, TOBYSIGN-D Eye/Ear Drops provide a powerful and convenient therapeutic solution for mixed bacterial infections with inflammation in both eyes and ears. Through its dual-action formulation and high manufacturing standards, it ensures rapid recovery, reduced complications, and patient comfort. With strong demand in ophthalmic and ENT markets globally, TOBYSIGN-D by BluepillExpress is a premium offering for companies seeking reliable, quality-assured third-party manufactured pharmaceuticals.